ALGRY SMART CHOLINE
LIVE

Serial Number

79219758

Owner

ALGRY QUIMICA, S.L.

Attorney

JOSE MARIA ARRUFAT

Filing Date

Jul 4, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ALGRY SMART CHOLINE Trademark

Serial Number: 79219758 • Registration: 5592417

ALGRY SMART CHOLINE is a trademark filed by ALGRY QUIMICA, S.L. on July 4, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ALGRY QUIMICA, S.L.

Mateo Inurria, 30

Entity Type: 99

Trademark Details

Filing Date

July 4, 2017

Registration Date

October 30, 2018

Published for Opposition

August 14, 2018

Cancellation Date

May 16, 2025

Goods & Services

Pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for prenatal support and for the normal development of the brain and the development of the memory center in the uterus; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for the development of the brain in infants; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for the development of memory in children; pharmaceutical products products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for the prevention of defects in the neural tube during fetal development; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for health and normal liver functions; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for promoting healthy heart conditions; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements to promote cerebral/cognitive health; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for the health of the liver; pharmaceutical products, namely, pharmaceutical preparations and pharmaceutical substances and nutraceuticals for its use as dietary supplements for sports nutrition; food for babies; disinfectants; sanitary preparations for medical use; dietetic foods and beverages adapted for medical use; food supplements for humans and animals; plasters for medical purposes; materials for dental fillings and dental impressions; preparations for destroying vermin; fungicides; herbicides; pharmaceutical preparations and substances for the prevention and treatment of normal brain development and development of the memory center of prenatal in uterus during pregnancy, for the prevention and treatment of disease and disorders of brain and memory development in children, for the prevention of neural tube defects in fetal development, for prevention and treatment of diseases and disorders of liver, for prevention and treatment of diseases and disorders of heart, for prevention and treatment of diseases and disorders of brain, for the prevention of diseases and disorders of neural defects during fetal development; veterinary preparations for the prevention of diseases and disorders of brain during fetal development in pregnancy phase of animals, for the prevention and treatment of diseases and disorders of brain in newborn animals, for the prevention and treatment of diseases and disorders of liver, heart and brain of animals, for the prevention of neural diseases and neural disorders during fetal development, for its use as food supplement for animals; pharmaceutical preparations for health care for the prevention of brain, liver and heart diseases; medicated serums for the treatment of brain, liver and heart diseases; vaccines

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 16, 2026 INTR
CANCELLED SECTION 71
May 16, 2025 C71T
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 1, 2025 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jan 9, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 30, 2023 REM3
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 21, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 21, 2019 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 4, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 4, 2019 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 1, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 7, 2019 FICS
FINAL DISPOSITION PROCESSED
Feb 7, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 30, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 30, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 14, 2018 NPUB
PUBLISHED FOR OPPOSITION
Aug 14, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Aug 11, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 25, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 25, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 25, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 3, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 6, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 6, 2018 TROA
REFUSAL PROCESSED BY IB
Dec 23, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 6, 2017 RFCS
REFUSAL PROCESSED BY MPU
Dec 6, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 22, 2017 RFCR
NON-FINAL ACTION WRITTEN
Nov 21, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 14, 2017 MAFR
ASSIGNED TO EXAMINER
Nov 9, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 8, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 2, 2017 REPR